{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:56:18Z","timestamp":1789966578058,"version":"4.0.1"},"reference-count":36,"publisher":"American Diabetes Association","issue":"7","license":[{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"vor","delay-in-days":92,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01-DK-094176"],"award-info":[{"award-number":["U01-DK-094176"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01-DK-094157"],"award-info":[{"award-number":["U01-DK-094157"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>The Diabetes Control and Complications Trial (DCCT)\/Epidemiology of Diabetes Interventions and Complications (EDIC) study has demonstrated the major role of hyperglycemia as a risk factor for clinical cardiovascular outcomes in type 1 diabetes (T1D). We assessed whether and to what extent the effect of glycemia is mediated by other established cardiovascular disease (CVD) risk factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>In the DCCT, 1,441 participants were randomized to receive either intensive or conventional diabetes therapy. The EDIC observational follow-up study enrolled 96% of the surviving DCCT cohort with 94% of the survivors still actively participating after more than 27 years of follow-up. Mediation of the effect of glycemia, as captured by HbA1c, on the subsequent CVD risk was quantified using the relative change in the CVD risk associated with HbA1c between models without and with the potential mediator.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Adjusted for age, only a few factors (e.g., pulse, triglycerides, albumin excretion rate) explained more than 10% of the effect of glycemia on CVD risk when considered individually. In multivariable models, these traditional risk factors together mediated up to \u223c50% of the effect of glycemia on the risk of CVD. However, the association between HbA1c and the risk of CVD remained highly significant even after adjustment for these risk factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>While HbA1c is associated with many traditional CVD risk factors, its association with these factors alone cannot explain its effects on risk of CVD. Consequently, aggressive management of traditional nonglycemic CVD risk factors, coupled with aggressive glycemic management, is indicated for individuals with type 1 diabetes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc18-1613","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T21:25:28Z","timestamp":1553117128000},"page":"1284-1289","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":55,"title":["Mediation of the Effect of Glycemia on the Risk of CVD Outcomes in Type 1 Diabetes: The DCCT\/EDIC Study"],"prefix":"10.2337","volume":"42","clinical-trial-number":[{"clinical-trial-number":"nct00360893","registry":"10.18810\/clinical-trials-gov","type":"results"},{"clinical-trial-number":"nct00360815","registry":"10.18810\/clinical-trials-gov","type":"results"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4944-7968","authenticated-orcid":false,"given":"Ionut","family":"Bebu","sequence":"first","affiliation":[{"name":"Biostatistics Center, The George Washington University, Rockville, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2184-9754","authenticated-orcid":false,"given":"Barbara H.","family":"Braffett","sequence":"additional","affiliation":[{"name":"Biostatistics Center, The George Washington University, Rockville, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor J.","family":"Orchard","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayle M.","family":"Lorenzi","sequence":"additional","affiliation":[{"name":"University of California, San Diego, San Diego, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9838-2841","authenticated-orcid":false,"given":"John M.","family":"Lachin","sequence":"additional","affiliation":[{"name":"Biostatistics Center, The George Washington University, Rockville, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the DCCT\/EDIC Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2019,3,20]]},"reference":[{"key":"2022031300530887100_B1","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.2337\/dc06-1161","article-title":"Type 1 diabetes and coronary artery disease","volume":"29","author":"Orchard","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031300530887100_B2","doi-asserted-by":"crossref","first-page":"e1001321","DOI":"10.1371\/journal.pmed.1001321","article-title":"Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study","volume":"9","author":"Livingstone","year":"2012","journal-title":"PLoS Med"},{"key":"2022031300530887100_B3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"2022031300530887100_B4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"2022031300530887100_B5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"},{"key":"2022031300530887100_B6","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031300530887100_B7","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031300530887100_B8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"2022031300530887100_B9","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJMoa0806359","article-title":"Long-term follow-up after tight control of blood pressure in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031300530887100_B10","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(09)60697-8","article-title":"Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials","volume":"373","author":"Ray","year":"2009","journal-title":"Lancet"},{"key":"2022031300530887100_B11","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s00125-009-1470-0","article-title":"Intensive glucose control and macrovascular outcomes in type 2 diabetes","volume":"52","author":"Turnbull","year":"2009","journal-title":"Diabetologia"},{"key":"2022031300530887100_B12","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2337\/diacare.26.5.1374","article-title":"Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study","volume":"26","author":"Orchard","year":"2003","journal-title":"Diabetes Care"},{"key":"2022031300530887100_B13","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1001\/archinte.164.17.1917","article-title":"Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy","volume":"164","author":"Klein","year":"2004","journal-title":"Arch Intern Med"},{"key":"2022031300530887100_B14","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.2337\/dc10-0398","article-title":"Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR)","volume":"33","author":"Eeg-Olofsson","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031300530887100_B15","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"2022031300530887100_B16","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/dc15-1990","article-title":"Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC study 30-year follow-up","volume":"39","author":"Diabetes Control and Complications Trial (DCCT)\/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031300530887100_B17","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2337\/db15-1517","article-title":"Risk factors for cardiovascular disease in type 1 diabetes","volume":"65","author":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Research Group","year":"2016","journal-title":"Diabetes"},{"key":"2022031300530887100_B18","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2337\/dc16-0502","article-title":"Coprogression of cardiovascular risk factors in type 1 diabetes during 30 years of follow-up in the DCCT\/EDIC study","volume":"39","author":"Writing Group for the DCCT\/EDIC Research Group","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031300530887100_B19","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1007\/s00125-017-4374-4","article-title":"The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT\/EDIC study","volume":"60","author":"Bebu","year":"2017","journal-title":"Diabetologia"},{"key":"2022031300530887100_B20","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2337\/diab.35.5.530","article-title":"The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase","volume":"35","author":"The DCCT Research Group","year":"1986","journal-title":"Diabetes"},{"key":"2022031300530887100_B21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2337\/diacare.22.1.99","article-title":"Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort","volume":"22","author":"The DCCT\/EDIC Research Group","year":"1999","journal-title":"Diabetes Care"},{"key":"2022031300530887100_B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diacare.10.1.1","article-title":"Diabetes Control and Complications Trial (DCCT): results of feasibility study","volume":"10","author":"The DCCT Research Group","year":"1987","journal-title":"Diabetes Care"},{"key":"2022031300530887100_B23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2337\/dc13-2116","article-title":"Update on cardiovascular outcomes at 30 years of the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications study","volume":"37","author":"Lachin","year":"2014","journal-title":"Diabetes Care"},{"key":"2022031300530887100_B24","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling Survival Data: Extending the Cox Model","author":"Therneau","year":"2000"},{"key":"2022031300530887100_B25","volume-title":"Introduction to Statistical Mediation Analysis","author":"MacKinnon","year":"2008"},{"key":"2022031300530887100_B26","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.2337\/dc12-2538","article-title":"Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study","volume":"36","author":"Maahs","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031300530887100_B27","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s00125-012-2817-5","article-title":"Revisiting the links between glycaemia, diabetes and cardiovascular disease","volume":"56","author":"Sattar","year":"2013","journal-title":"Diabetologia"},{"key":"2022031300530887100_B28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2337\/dc13-2113","article-title":"Kidney disease and related findings in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications study","volume":"37","author":"de Boer","year":"2014","journal-title":"Diabetes Care"},{"key":"2022031300530887100_B29","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1056\/NEJMoa1111732","article-title":"Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes","volume":"365","author":"de Boer","year":"2011","journal-title":"N Engl J Med"},{"key":"2022031300530887100_B30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/00365519109091641","article-title":"Impaired left-ventricular function in insulin-dependent diabetic patients with increased urinary albumin excretion","volume":"51","author":"Kelbaek","year":"1991","journal-title":"Scand J Clin Lab Invest"},{"key":"2022031300530887100_B31","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jacc.2007.04.079","article-title":"Resting heart rate in cardiovascular disease","volume":"50","author":"Fox","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022031300530887100_B32","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/0002-8703(87)90666-1","article-title":"Heart rate and cardiovascular mortality: the Framingham Study","volume":"113","author":"Kannel","year":"1987","journal-title":"Am Heart J"},{"key":"2022031300530887100_B33","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1089\/ars.2009.2484","article-title":"Hyperglycemia and glycation in diabetic complications","volume":"11","author":"Negre-Salvayre","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"2022031300530887100_B34","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/00004872-200311000-00012","article-title":"Pulse pressure is associated with age and cardiovascular disease in type 1 diabetes: the Eurodiab Prospective Complications Study","volume":"21","author":"Schram","year":"2003","journal-title":"J Hypertens"},{"key":"2022031300530887100_B35","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2337\/dc10-2013","article-title":"Pulse pressure predicts incident cardiovascular disease but not diabetic nephropathy in patients with type 1 diabetes (the FinnDiane Study)","volume":"34","author":"Gordin","year":"2011","journal-title":"Diabetes Care"},{"key":"2022031300530887100_B36","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2337\/diabetes.49.4.626","article-title":"Can clinical factors estimate insulin resistance in type 1 diabetes","volume":"49","author":"Williams","year":"2000","journal-title":"Diabetes"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc18-1613","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/7\/1284\/530216\/dc181613.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/7\/1284\/530216\/dc181613.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T04:23:28Z","timestamp":1647145408000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/42\/7\/1284\/36246\/Mediation-of-the-Effect-of-Glycemia-on-the-Risk-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,20]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,3,20]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc18-1613","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,20]]}}}